A recurrent giant cell tumor of bone treated with denosumab
AbstractAlthough the giant cell tumor of bone is generally classified as a benign tumor it can rarely metastasize and has a potential risk of local recurrence. We want to report about a female patient who suffered from a recurrence of a giant cell tumor of bone after the implantation of a total endoprosthesis of the knee joint. We have treated her with denosumab, which is a receptor activator of nuclear factor kappa-B ligand inhibitor. In this case report we want to present a new option to treat this kind of neoplasm.
Google ScholarGoogle Scholar
- Abstract views: 1186
- PDF: 538
- HTML: 476
Copyright (c) 2015 Nicola Stadler, Thomas Fingernagel, Stefan G. Hofstaetter, Klemens Trieb
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.